agilon health is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. agilon health enables physicians to create their own Medicare-centric globally capitated line of business. The agilon Total Care Model is powered by its purpose-built platform and enabled through a growing national network of like-minded physician partners. With agilon, physicians are freed from the constraints of the transactional fee-for-service reimbursement model and are able to practice team-based, coordinated care to serve the individual needs of their senior patients and to transition to a sustainable and predictable, long-term business model. The rapidly growing appeal of the agilon platform, partnership model and network of leading community-based physicians has allowed the company to expand to 17 local communities with 16 anchor physician groups, as well as a network of physicians across Hawaii, in fewer than five years.
Company profile
Ticker
AGL
Exchange
Website
CEO
Steve Sell
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
Agilon Health Topco, Inc.
SEC CIK
Corporate docs
Subsidiaries
Agilon Equity PPCP Holdings, LLC • agilon health Catalyst Health Network ACO, Inc. • agilon health Coastal DCE, Inc. • agilon health Coastal DCE Inc. • agilon health Columbus Ohio DCE, Inc. • Agilon Health Holdings, Inc. • Agilon health Kentucky ACO, Inc. • agilon health of California, Inc. • agilon health management, inc. • Agilon Health India Private Limited ...
IRS number
371915147
AGL stock data
Analyst ratings and price targets
Latest filings (excl ownership)
8-K
Guidance for 2023 includes significant gains in Adjusted EBITDA to $75 million to $90 million while maintaining strong revenue and membership growth1
1 Mar 23
10-K
2022 FY
Annual report
1 Mar 23
8-K
Departure of Directors or Certain Officers
22 Feb 23
8-K
Regulation FD Disclosure
9 Jan 23
8-K
Departure of Directors or Certain Officers
20 Dec 22
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
Total members live on the agilon platform grew to 356,000, including 266,600 Medicare Advantage members and 89,400 Direct Contracting beneficiaries
3 Nov 22
8-K
Departure of Directors or Certain Officers
30 Sep 22
8-K
Departure of Directors or Certain Officers
10 Aug 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
Transcripts
AGL
Earnings call transcript
2022 Q3
3 Nov 22
AGL
Earnings call transcript
2022 Q2
6 Aug 22
AGL
Earnings call transcript
2022 Q1
8 May 22
AGL
Earnings call transcript
2021 Q4
4 Mar 22
AGL
Earnings call transcript
2022 Q4
1 Mar 22
AGL
Earnings call transcript
2021 Q3
29 Oct 21
AGL
Earnings call transcript
2021 Q2
7 Aug 21
AGL
Earnings call transcript
2021 Q1
27 May 21
Latest ownership filings
4
Veeral Desai
27 Mar 23
144
Notice of proposed sale of securities
24 Mar 23
4
Benjamin Kornitzer
24 Mar 23
144
Notice of proposed sale of securities
23 Mar 23
4
John William Wulf
17 Mar 23
4
Benjamin Shaker
17 Mar 23
4
Benjamin Kornitzer
17 Mar 23
4
Veeral Desai
17 Mar 23
SC 13G/A
Capital World Investors
10 Mar 23
4
Benjamin Kornitzer
9 Mar 23
Financial summary
Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 507.68 mm | 507.68 mm | 507.68 mm | 507.68 mm | 507.68 mm | 507.68 mm |
Cash burn (monthly) | 18.93 mm | 45.60 mm | 23.04 mm | 10.07 mm | 16.65 mm | 10.90 mm |
Cash used (since last report) | 54.91 mm | 132.23 mm | 66.82 mm | 29.21 mm | 48.30 mm | 31.61 mm |
Cash remaining | 452.77 mm | 375.45 mm | 440.86 mm | 478.47 mm | 459.38 mm | 476.07 mm |
Runway (months of cash) | 23.9 | 8.2 | 19.1 | 47.5 | 27.6 | 43.7 |
Institutional ownership, Q4 2022
13F holders | Current |
---|---|
Total holders | 175 |
Opened positions | 39 |
Closed positions | 49 |
Increased positions | 61 |
Reduced positions | 61 |
13F shares | Current |
---|---|
Total value | 6.93 tn |
Total shares | 626.06 mm |
Total puts | 380.50 k |
Total calls | 771.80 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
Clayton, Dubilier & Rice | 194.61 mm | $3.14 tn |
CD&R Vector | 194.61 mm | $0.00 |
FMR | 46.67 mm | $753.27 bn |
MS Morgan Stanley | 38.44 mm | $620.42 bn |
Capital World Investors | 37.92 mm | $612.00 bn |
Wellington Management | 22.75 mm | $367.11 bn |
Vanguard | 19.25 mm | $310.65 bn |
Capital Research Global Investors | 13.43 mm | $216.74 bn |
Durable Capital Partners | 8.84 mm | $142.72 bn |
BLK Blackrock | 8.69 mm | $140.19 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 Mar 23 | Veeral Desai | Common Stock | Sell | Dispose S | No | Yes | 28.7016 | 97,290 | 2.79 mm | 276,729 |
24 Mar 23 | Veeral Desai | Common Stock | Option exercise | Acquire M | No | No | 3 | 97,290 | 291.87 k | 374,019 |
24 Mar 23 | Veeral Desai | Options (Rights to Buy) Common Stock | Option exercise | Dispose M | No | No | 3 | 97,290 | 291.87 k | 1,520,000 |
23 Mar 23 | Veeral Desai | Common Stock | Sell | Dispose S | No | Yes | 28.7059 | 22,710 | 651.91 k | 276,729 |
23 Mar 23 | Veeral Desai | Common Stock | Option exercise | Acquire M | No | No | 3 | 22,710 | 68.13 k | 299,439 |
23 Mar 23 | Veeral Desai | Options (Rights to Buy) Common Stock | Option exercise | Dispose M | No | No | 3 | 22,710 | 68.13 k | 1,617,290 |
23 Mar 23 | Benjamin Kornitzer | Common Stock | Sell | Dispose S | No | Yes | 28.0428 | 8,094 | 226.98 k | 55,426 |
23 Mar 23 | Benjamin Kornitzer | Common Stock | Option exercise | Acquire M | No | No | 8.99 | 8,094 | 72.77 k | 63,520 |
23 Mar 23 | Benjamin Kornitzer | Options (Rights to Buy) Common Stock | Option exercise | Dispose M | No | No | 8.99 | 8,094 | 72.77 k | 125,000 |
22 Mar 23 | Benjamin Kornitzer | Common Stock | Sell | Dispose S | No | Yes | 27.8448 | 8,094 | 225.38 k | 55,426 |
News
It's Not Tesla, Meta Or Nvidia — The Best Performing Large-Cap Stock In 2023 Is A Crypto Play
27 Mar 23
Guggenheim Maintains Buy on Agilon Health, Raises Price Target to $30
6 Mar 23
Agilon Health Q4 EPS $(0.14) Misses $(0.09) Estimate, Sales $689.77M Beat $664.36M Estimate
1 Mar 23
Earnings Scheduled For March 1, 2023
1 Mar 23
Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday
9 Jan 23
Press releases
agilon health to Host Investor Day on March 30
15 Mar 23
agilon health Reports Fourth Quarter and Fiscal Year 2022 Results
1 Mar 23
agilon health Announces Acquisition of mphrX, a Leading Healthcare Technology Company
1 Mar 23
Family Practice Center (FPC) Partners with agilon health to Deliver New Level of Value-Based Care for Central Pennsylvanians
28 Feb 23
agilon health Names Diana McKenzie to Board of Directors
22 Feb 23